2 Sources
[1]
Dassault Systèmes to acquire ArisGlobal from Nordic Capital By Investing.com
WALTHAM, Mass. - Nordic Capital announced today it has entered into a definitive agreement to sell ArisGlobal, a provider of software to the life sciences industry, to Dassault Systèmes (Euronext Paris:FR0014003TT8). The transaction represents a full exit for Nordic Capital, which first invested in ArisGlobal in 2019 and made an additional investment in 2021, according to a press release statement. ArisGlobal, founded in 1989 and headquartered in Waltham, Massachusetts, develops regulatory, safety and quality software for pharmaceutical and biotech organizations. The company's LifeSphere platform is a cloud-native suite that enables life sciences organizations to manage regulatory submissions, pharmacovigilance workflows and clinical data. ArisGlobal serves more than 200 enterprise customers, including half of the world's top 50 biopharma companies, and processes more than 12 million safety cases annually. The company is expected to generate approximately $175 million in revenue in 2026. "The partnership with Nordic Capital gave us the resources and the runway to build exactly that. NavaX and our expanded platform are the result of that ambition, and I am confident we are well placed for what comes next," said Aman Wasan, CEO of ArisGlobal. During Nordic Capital's ownership, ArisGlobal developed NavaX, a generative AI solution for safety case processing that has been adopted by pharmaceutical companies. The company also completed two strategic acquisitions to broaden its platform capabilities. "Nordic Capital is proud of what has been achieved together with management and looks forward to seeing the company continue to grow under Dassault Systèmes ownership," said Daniel Berglund, Partner and Head of Healthcare at Nordic Capital Advisors. The transaction is subject to customary regulatory approvals and is expected to close in the second half of 2026. Evercore and Jefferies LLC acted as financial advisors to ArisGlobal, while Kirkland & Ellis served as legal advisor. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
[2]
Dassault Systemes to Buy ArisGlobal for Up to $2 Billion
Dassault Systemes said it agreed to buy Nordic Capital's ArisGlobal, a U.S. supplier of software to the life-sciences industry, for up to $2 billion, seeking to bolster its artificial-intelligence offering. French software company Dassault Systemes said Thursday that it is buying ArisGlobal for about $1.8 billion in cash at closing and up to $200 million in additional payments linked to AI-related revenue targets. Dassault Systemes said the deal would allow it to capitalize on the life-sciences' shift to AI and precision medicine. The company expects the acquisition to help revenue growth and earnings per share in the first year after completion, which is anticipated in the second half subject to regulatory approvals and other customary conditions. Nordic Capital acquired majority ownership of ArisGlobal in 2019.
Share
Copy Link
French software giant Dassault Systèmes has agreed to acquire ArisGlobal, a life sciences software company, from Nordic Capital for up to $2 billion. The acquisition aims to capitalize on the industry's shift toward artificial intelligence and precision medicine, with additional payments tied to AI-related revenue targets.
Dassault Systèmes has entered into a definitive agreement to acquire ArisGlobal from Nordic Capital for up to $2 billion, marking a significant expansion of the French software company's artificial intelligence capabilities in the life sciences sector
2
. The deal structure includes approximately $1.8 billion in cash at closing, with an additional $200 million in payments linked to AI-related revenue targets2
. This acquisition represents a full exit for Nordic Capital, which first invested in the life sciences software company in 2019 and made an additional investment in 20211
.Founded in 1989 and headquartered in Waltham, Massachusetts, ArisGlobal develops regulatory, safety and quality software for pharmaceutical and biotech organizations
1
. The company's LifeSphere platform serves as a cloud-native suite that enables life sciences organizations to manage regulatory submissions, pharmacovigilance workflows and clinical data1
. With more than 200 enterprise customers, including half of the world's top 50 biopharma companies, ArisGlobal processes more than 12 million safety cases annually1
. The company is expected to generate approximately $175 million in revenue in 20261
.During Nordic Capital's ownership, ArisGlobal developed NavaX, a generative AI solution for safety case processing that has been adopted by pharmaceutical companies
1
. This technology positions the acquisition as particularly valuable for Dassault Systèmes as it seeks to capitalize on the life sciences industry's shift to AI and precision medicine2
. The company also completed two strategic acquisitions to broaden its platform capabilities under Nordic Capital's stewardship1
. Aman Wasan, CEO of ArisGlobal, stated that the partnership with Nordic Capital provided the resources to build NavaX and expand the platform1
.Related Stories
Dassault Systèmes expects the acquisition to contribute to revenue growth and earnings per share in the first year after completion
2
. The transaction is subject to customary regulatory approvals and is expected to close in the second half of 20261
. Evercore and Jefferies LLC acted as financial advisors to ArisGlobal, while Kirkland & Ellis served as legal advisor1
. Daniel Berglund, Partner and Head of Healthcare at Nordic Capital Advisors, expressed pride in what has been achieved together with management and looks forward to seeing the company continue to grow under Dassault Systèmes ownership1
.Summarized by
Navi
[2]
03 Apr 2025•Business and Economy

25 Jul 2024

31 Oct 2024•Business and Economy

1
Technology

2
Policy and Regulation

3
Science and Research
